Menu
/REGISTER
Montecito
Tolman Wiker
Pac Premier
Fielding
Farmers merchants
Nixon Peabody
Express Pros
Loading...
You are here:  Home  >  Health Care  -  Page 50

Montecito Bank & Trust

Santa Barbara Web Design
Latest

Inogen reports huge increase in net income

By   /  Tuesday, February 28th, 2017  /  Earnings, Health Care, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Inogen reports huge increase in net income

Inogen, a maker of portable oxygen concentrators based in Goleta, announced a 77 percent increase in net income Feb. 28 on fourth quarter revenues of $50.9 million. Sales revenues grew 47.2 percent over the same quarter in 2015, to $42.6 million. Net income for the quarter was $5.3 million, bringing the company up to $20.5 Read More →

Read More →
Latest

Genentech sues Amgen over biosimilar drug info

By   /  Monday, February 20th, 2017  /  Health Care, Latest news, Technology  /  Comments Off on Genentech sues Amgen over biosimilar drug info

Roch AG subsidiary Genentech filed a lawsuit against Amgen claiming the Thousand Oaks-based company obstructed its investigation of whether the biosimilar Amgen is developing for Genentech’s cancer treatment Avastin violates the company’s patents, according to reports Feb. 20. Sales for Avastin, a treatment for lung, colon, ovarian and other types of cancer, reached $6.8 billion Read More →

Read More →
Latest

Amgen applies for FDA approval of Blincyto

By   /  Tuesday, February 14th, 2017  /  Health Care, Latest news, Technology  /  Comments Off on Amgen applies for FDA approval of Blincyto

Thousand Oaks-based Amgen submitted an application for Blincyto to the U.S. Food and Drug Administration, the company announced on Feb. 14. Amgen aims to gain approval for Blincyto to treat Philadelphia chromosome-positive relapsed or refractory B-cell precursor acute lymphoblastic leukemia. The drug was previously granted breakthrough therapy designation and accelerated approval in December 2014. “Acute Read More →

Read More →
Latest

Drug sales for biotech giant Amgen boost bottom line

By   /  Friday, February 10th, 2017  /  Earnings, Health Care, left, Technology, Tri-County Public Companies  /  Comments Off on Drug sales for biotech giant Amgen boost bottom line

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Atara Biotherapeutics moving research division to Thousand Oaks

By   /  Wednesday, February 8th, 2017  /  Health Care, Latest news, Technology  /  Comments Off on Atara Biotherapeutics moving research division to Thousand Oaks

Atara Biotherapeutics will move its research and development division from Westlake Village to Thousand Oaks, the company said in a news release. The company plans to occupy 91,000 square feet at the yet-to-be-constructed Conejo Spectrum Business Park off of Lawrence Drive and Conejo Spectrum Street. The Sares-Regis Group bought 29 acres of land at the Read More →

Read More →
Latest

FDA approves Amgen’s Parsabiv drug to treat chronic kidney disease

By   /  Tuesday, February 7th, 2017  /  Health Care, Latest news  /  Comments Off on FDA approves Amgen’s Parsabiv drug to treat chronic kidney disease

The U.S. Food and Drug Administration approved Amgen’s Parsabiv drug to treat patients with chronic kidney disease, the company announced on Feb. 7. The Thousand Oaks-based biotech company’s Parsabiv is the first therapy approved for the treatment of secondary hyperparathyroidism for patients on hemodialysis in 12 years, Amgen said. “We are excited about today’s approval Read More →

Read More →
Latest

Amgen funds STEM program for Girl Scouts

By   /  Friday, February 3rd, 2017  /  Education, Health Care, Latest news, Nonprofits  /  Comments Off on Amgen funds STEM program for Girl Scouts

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →